Controlled release of U-86983 from double-layer biodegradable matrices: Effect of additives on release mechanism and kinetics

Journal of Controlled Release

Volumn 45, Issue 2, 1997, Pages 177-192

  Song, C X ^a   Labhasetwar, V ^a,b   Levy, R J ^a,b  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Additives; Morphology; Poly(lactic co glycolic acid) (PLGA); Release kinetics; Restenosis

Indexed keywords

2 HYDROXYPROPYL BETA CYCLODEXTRIN; BETA CYCLODEXTRIN DERIVATIVE; CHROMONE DERIVATIVE; DRUG ADDITIVE; POLOXAMER; POLYGLACTIN; PROPOLIS; TARTARIC ACID DERIVATIVE; U 86983; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED RELEASE FORMULATION; DIFFERENTIAL SCANNING CALORIMETRY; DIFFUSION; DRUG DELIVERY SYSTEM; DRUG RELEASE; KINETICS; MATRIX TABLET; MOLECULAR SIZE; PRIORITY JOURNAL; RESTENOSIS; SCANNING ELECTRON MICROSCOPY;

EID: 0031059505     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-3659(96)01551-9     Document Type: Article

References (21)

1. D.H. Lewis, Controlled release of bioactive agents from lactide/glycolide polymers, in: M. Chasin and R. Langer (Eds.), Biodegradable Polymers as Drug Delivery Systems, Marcel Dekker, Inc. New York, NY, 1990, pp. 1-42.
2. P.P. DeLuca, R.C. Mehta, A.G. Hausberger and B.C. Thanoo, Biodegradable polyesters for drug and polypeptide delivery, in: M.A. El-Nokaly, D.M. Piatt and B.A. Charpentier (Eds.), Polymeric Delivery Systems: Properties and Applications, American Chemical Society, Washington, D.C., 1993, pp. 53-79.
3. C.G. Pitt, M.M. Gratzl, G.L. Kimmel, J. Surles and A. Schindler, Aliphatic polyesters: II. The degradation of poly (d,l-lactide), poly (ε-caprolactone) and their co-polymers in vivo, Biomaterials 2 (1981) 215-220.
4. D.H. Lewis and T.R. Tice, Polymeric considerations in the design of microencapsulated contraceptive steroids, in: G.I. Zatuchni (Ed.), Long-Acting Contraceptive Delivery Systems, Harper and Row, Philadelphia, 1984, pp. 77-95.
5. S.S. Shah, Y. Cha and C.G. Pitt, Poly(glycolic acid-co-d,l-lactic acid): diffusion or degradation controlled drug delivery? J. Control. Release 18 (1992) 261-270.
6. C.C. Haudenschild, Pathobiology of restenosis after angioplasty, Am. J. Med. 94 (1993) 40S-44S.
7. A. Villa, L. Guzman, W. Chen, G. Golomb, R. Levy and E. Topol, Local delivery of dexamethasone for prevention of neointimal proliferation in rat model of balloon angioplasty. J. Clin. Invest. 93 (1994) 1243-1249.
8. F.G. Hutchinson and B.J.A. Furr, Biodegradable polymer systems for the sustained release of polypeptides, J. Control. Release 13 (1990) 279-294.
9. Miller, J.M. Brady and D.E. Culright, Degradation rate of oral resorbable implants (polylactates and polyglycolates): rate modulation with changes in PLA/PGA co-polymer ratios, J. Biomed. Mater. Res. 11 (1977) 711-715.
10. S. Cohen, T. Yshioka, M. Lucarelli, L.H. Hwaug and R. Langer, Controlled delivery systems for proteins based on poly(lactic/glycolic acid) microspheres, Pharm. Res. 8 (1991) 713-720.
11. Z. Brich, F. Nimmerfall, T. Kissel and S. Bantle, Branched ter-polymers: Synthesis, characterization in vitro and in vivo degradation behaviors, Proc. Intern. Symp. Control. Rel. Bioact. Mater. 15 (1988) 95-96.
12. M. Donbrow, Introduction and Overview, in: M. Donbrow (Ed.), Microcapsules and Nanoparticles in Medicine and Pharmacy, CRC Press, Boca Raton, FL, 1992, pp. 1-14.
13. C.X. Song, V. Labhasetwar, H. Murphy, X. Qu, W.R. Humphrey, R.J. Shebuski and R.J. Levy, Formulation and characterization of biodegradable nanoparticles for intravascular local drug delivery, J. Control. Release, (1996) In press.
14. B. Berner and S.M. Dinh, Fundamental concepts in controlled release, in: A. Kydonieus (Ed.), Treatise on Controlled Drug Delivery, Fundamentals, Optimization, Applications, Marcel Dekker, Inc. New York, NY, 1992, pp. 1-36.
15. K.W. Leong, Synthetic biodegradable polymer drug delivery systems, in: P.J. Tarcha (Ed.), Polymers For Controlled Drug delivery, CRC Press, Inc., Boca Raton, FL, 1991, pp. 128-148.
16. R.A. Kenley, M.O. Lee, T.R. Mahoney II, and L.M. Sanders, Poly(lactide-co-glycolide) decomposition kinetics in vitro and in vivo, Macromolecules 20 (1987) 2398-2403.
17. 2+ ion. J. Microencaps. 2 (1985) 13-19.
18. P.B. Deasy, M.R. Brophy, B. Ecanow and M.M. Joy, Effect of ethylcellulose grade and sealant treatments on the production and in vitro release of microencapsulated sodium salicylate. J. Pharm. Pharmacol. 32 (1980) 15-19.
19. W-Y. Kuu, R.W. Wood and T.J. Roseman, Factors influencing the kinetics of solute release, in: A. Kydonieus (Ed.), Treatise on Controlled Drug Delivery, Fundamentals, Optimization, Applications, Marcel Dekker, Inc. New York, NY, 1992, pp. 37-154.
20. J.M. Ruiz, J.P. Busnel and J.P. Benoit, Influence of average molecular weights of poly(d,l-lactic acid-co-glycolic acid) copolymers 50/50 on phase separation and in vitro drug release from microspheres. Pharm. Res. 7(9) (1990) 928-934.
21. J.M. Ruiz and J.P, Benoit, In vivo peptide release from poly(d,l-lactic acid-co-glycolic acid) copolymer 50/50 microspheres. J. Control. Release 16 (1991) 177-186.